NCT01442584

Brief Summary

Ovarian transplantation has been shown to restore fertility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started Jul 2011

Longer than P75 for not_applicable pregnancy

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2011

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 28, 2011

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

September 28, 2011

Status Verified

July 1, 2011

Enrollment Period

4.4 years

First QC Date

July 13, 2011

Last Update Submit

September 27, 2011

Conditions

Pregnancy

Keywords

ovarycortextransplantation

Outcome Measures

Primary Outcomes (1)

  • pregnancy

    we will start IVF within 3 months

    3-6 months

Study Arms (1)

fertility restoration by transplantation

EXPERIMENTAL

fertility restoration by transplantation of ovarian cortex slivers that were cryopreserved prior to chemotherapy

Procedure: ovarian transplantation

Interventions

ovarian transplantationPROCEDURE

ovarian transplantation

Also known as: frozen thawed ovarian cortex transplantation
fertility restoration by transplantation

Eligibility Criteria

Age20 Years - 54 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients who froze ovarian tissue

You may not qualify if:

  • malignant cells in ovary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah

Jerusalem, Israel

RECRUITING

Study Officials

  • Ariel Revel, MD

    Hadassah

    STUDY CHAIR

Central Study Contacts

ariel revel, md

CONTACT

97226777111arielr2@hadassah.org.il

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 13, 2011

First Posted

September 28, 2011

Study Start

July 1, 2011

Primary Completion

December 1, 2015

Study Completion

January 1, 2016

Last Updated

September 28, 2011

Record last verified: 2011-07

Locations

IL(1)